Skip to main content

Advertisement

Log in

Unreliability in the Treatment of Patients with Peritoneal Metastases of Colorectal Cancer in the Current NCCN and ASCO Recommendations

  • Colorectal Cancer
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Morris V, Kennedy E, Baxter N, Benson A III, Cercek A, Cho M, et al. Treatment of metastatic colorectal cancer: ASCO Guideline. J Clin Oncol. 2022;41:678–700.

    Article  PubMed  Google Scholar 

  2. Nagourney R, Evans S, Tran P, Nagourney A, Sugarbaker P. Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin. Eur J Surg Oncol. 2021;47:738–42.

    Article  PubMed  Google Scholar 

  3. Quénet F, Elias D, Roca L, Goéré D, Ghouti L, Pocard M, et al.; UNICANCER-GI Group and BIG Renape Group. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicenter, randomized, open-label, phase 3 trial. Lancet Oncol. 2021;22:256-66.

  4. Verwaal V, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426–32.

    Article  PubMed  Google Scholar 

  5. https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomasz Jastrzebski MD, PhD.

Ethics declarations

Disclosure

I have no any commercial interest that any author may have in the subject of study or the source of any financial or material support.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jastrzebski, T. Unreliability in the Treatment of Patients with Peritoneal Metastases of Colorectal Cancer in the Current NCCN and ASCO Recommendations. Ann Surg Oncol 30, 3989–3990 (2023). https://doi.org/10.1245/s10434-023-13576-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13576-3

Navigation